Characterization of tumorigenic cell lines from the recurrence and lymph node metastasis of a human salivary mucoepidermoid carcinoma

Oral Oncology

Volumn 49, Issue 11, 2013, Pages 1059-1066

  Warner, Kristy A ^a   Adams, April ^a   Bernardi, Lisiane ^a   Nor, Carolina ^a   Finkel, Kelsey A ^a   Zhang, Zhaocheng ^a   McLean, Scott A ^b   Helman, Joseph ^a   Wolf, Gregory T ^b   Divi, Vasu ^c   Queimado, Lurdes ^d   Kaye, Frederic J ^e   Castilho, Rogerio M ^a   Nör, Jacques E ^a,b,f  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f The Department of Civil and Environmental Engineering   (United States)

Author keywords

Crtc1 Maml2; Metastasis; Mouse models; Oral cancer; Salivary gland cancer; Tumor recurrence; Xenograft

Indexed keywords

ADENOSQUAMOUS CARCINOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CARCINOMA CELL; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; ONCOGENE; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SALIVARY GLAND CARCINOMA; SCID MOUSE; SHORT TANDEM REPEAT; TUMOR XENOGRAFT;

CRTC1-MAML2; METASTASIS; MOUSE MODELS; ORAL CANCER; SALIVARY GLAND CANCER; TUMOR RECURRENCE; XENOGRAFT;

AGED; ANIMALS; CARCINOMA, MUCOEPIDERMOID; CELL LINE, TUMOR; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, EXPERIMENTAL; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 2; ONCOGENE PROTEINS, FUSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS;

EID: 84888640572     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.08.004     Document Type: Article

References (30)

1. Ellis GL, Auclair PL. Mucoepidermoid carcinoma. In: Rosai J, Sobin LH, editors. Tumors of the salivary glands. Washington, DC: Armed Forces Institute of Pathology; 1996. p. 155-72.
2. Chandana SR, Conley BA. Salivary gland cancers: current treatments, molecular characteristics and new therapies. Expert Rev 2008;8:645-52.
3. Andry G, Hamoir M, Locati LD, Licitra L, Langendijk JA. Management of salivary gland tumors. Expert Rev 2012;12:1161-8.
4. Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol 2009;3:69-77.
5. Volkmann I. Über endotheliale Geschwülste zugleich ein Beitrag zu den Speicheldrüsen und Caumentumoren. Dtsch Z Chir 1895;41:1.
6. McHugh CH, Roberts DB, El-Naggar AK, Hanna EY, Garden AS, Kies MS, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer 2012;118:3928-36.
7. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer 1998;82:1217-24.
8. Bai S, Clubwala R, Adler E, Sarta C, Schiff B, Smith RV, et al. Salivary mucoepidermoid carcinoma: a multi-institutional review of 76 patients. Head Neck Pathol 2012;7(2):105-12.
9. Tonon G, Modi S, Wu L, Kubo A, Coxon AB, Komiya T, et al. T(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet 2003;33:208-13.
10. Okabe M, Miyabe S, Nagatsuka H, Terada A, Hanai N, Yokoi M, et al. MECTMAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin Cancer Res 2006;12:3902-7.
11. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. CRTC1/ MAML2 fusion transcript in high-grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer 2007;46:708-15.
12. Behboudi A, Enlund F, Winnes M, Andrén Y, Nordkvist A, Leivo I, et al. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer 2006;45:470-81.
13. Anzick SL, Chen WD, Park Y, Meltzer P, Bell D, El-Naggar AK, et al. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer 2010;49:59-69.
14. Komiya T, Park Y, Modi S, Coxon AB, Oh H, Kaye FJ. Sustained expression of Mect1-Maml2 is essential for tumor cell growth in salivary gland cancers carrying the t(11;19) translocation. Oncogene 2006;25:6128-32.
15. Kaye FJ. Emerging biology of malignant salivary gland tumors offers new insights into the classification and treatment of mucoepidermoid cancer. Clin Cancer Res 2006;12:3878-81.
16. Grénman R, Pekkola-Heino K, Joensuu H, Aitasalo K, Klemi P, Lakkala T. UTMUC- 1, a new mucoepidermoid carcinoma cell line, and its radiosensitivity. Arch Otolaryngol Head Neck Surg 1992;118:542-7.
17. Queimado L, Lopes C, Du F, Martins C, Fonseca I, Bowcock AM, et al. In vitro transformation of cell lines from human salivary gland tumors. Int J Cancer 1999;81:793-8.
18. Coxon A, Rozenblum E, Park YS, Joshi N, Tsurutani J, Dennis PA, et al. Mect1- Maml2 fusion oncogene linked to aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res 2005;65:7137-44.
19. Nör JE, Peters MC, Christensen JB, Sutorik MM, Linn S, Khan MK, et al. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 2001;81:453-63.
20. Nör JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, et al. Up- Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001;61:2183-8.
21. Panicker N, Jariwala P, Buch A, Joshi M. The utility of periodic acid Schiff with diastase and alcian blue stains on fine needle aspirates of breast and salivary gland neoplasms. J Cytol 2012;29:221-5.
22. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Delerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007;104(3):973-8.
23. Locke M, Heywood M, Fawell S, Mackenzie IC. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 2005;65(19):8944-50.
24. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100(7):3983-8.
25. Adams A, Warner K, Nör JE. Salivary gland cancer stem cells. Oral Oncol 2013[Jun 27, Epub ahead of print].
26. Alston-Roberts C, Barallon R, Bauer SR, Butler J, Capes-Davis A, Dirks WG, et al. Cell line misidentification: the beginning of the end. Nat Rev Cancer 2010;10:441-8.
27. Butler JM. Genetics and genomics of core short tandem repeat loci used in human identity testing. J Forens Sci 2006;51:253-65.
28. Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, et al. DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther 2009;8:713-24.
29. Phuchareon J, Ohta Y, Woo JM, Eisele DW, Tetsu O. Genetic profiling reveals cross-contamination and misidentification of 6 adenoid cystic carcinoma cell lines: ACC2, ACC3, ACCM, ACCNS, ACC5 and CAC2. PLoS ONE 2009;4:1-7.
30. Enlund F, Behboudi A, Andrén Y, Oberg C, Lendahl U, Mark J, et al. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors. Exp Cell Res 2004;292:21-8.